Novartis gets slapped by ethics overseer for dissing Bayer's Eylea; CRO WuXi plans $3.3B management buyout;

@FiercePharma: China FDA issues software guidelines on medical devices effective this month. FiercePharmaAsia story | Follow @FiercePharma

@EricPFierce: Sun U.S. sales gut-kicked by supply constraints as it works on FDA concerns at Halol plant. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Biogen touts new Eloctate data as next-gen hemophilia rivals near the scene. FiercePharmaMarketing article | Follow @CarlyHFierce

> England's code of conduct regulator has ruled in favor of Bayer in a fight with Novartis ($NVS) over claims the Swiss drugmaker made at a conference concerning the two companies' rival eye drugs, Eylea and Aventis. Report

> Chinese CRO WuXi PharmaTech ($WX) has agreed to a $3.3 billion management buyout. Release | More

> Abbott Laboratories ($ABT) has sold to a development group a four-story office building in the Dallas area that it recently vacated. Report

> Pfizer ($PFE) has won another regulator's approval for its $15 billion buyout of Hospira ($HSP), this one from Canada. Release

Medical Device News

@FierceMedDev: Roche shells out up to $425M for superbug testing outfit. FierceDiagnostics news | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Google joins forces with Dexcom for miniaturized glucose monitor. Article | Follow @VarunSaxena2

@EmilyWFierce: NICE plots takeover of England's Cancer Drugs Fund. FiercePharma article | Follow @EmilyWFierce

> NOWDiagnostics gets FDA blessing for one-step pregnancy test. News

> Roche deploying smartphone app to monitor patients during clinical trial of its Parkinson's med. Report

> NIH study sees little benefit to added fetal ECG monitoring during birth. Story

Biotech News

@FierceBiotech: FierceBiotech Radio on Amarin's First Amendment crusade, Martin Shkreli's Twitter, and Kim Kardashian's Instagram. Listen/Subscribe | Follow @FierceBiotech

@JohnCFierce: California cutbacks: Boston Sci to close two facilities, Abbott cuts 160+ employees. FierceMedicalDevices article | Follow @JohnCFierce

@DamianFierce: ICYMI: A wonderfully stern FDA official parses Kim Kardashian's Instagram. Letter | Follow @DamianFierce

> KemPharm spikes as its anti-abuse pain drug rolls toward the FDA. Story

> Lilly's CEO keeps faith in the pipeline as biotech gets 'too expensive.' Article

> CRO giant WuXi is going private in a $3.3B deal. News

> Avalanche hits the brakes on its gene therapy program after a Phase II misstep. Report

And Finally... Scientists have invented a quick method to make potent opioid painkillers using bioengineered baker's yeast instead of poppies, but they need to fine-tune the process to make it commercially viable, a new study says. More

Suggested Articles

Belgian CDMO Ajinomoto Bio-Pharma Services has been on a run in recent of years expanding its operations around the world. That was the goal of an Ind

The company will commit $300 million over the next five years to hire more people of color and increase clinical trial diversity.

Moderna, after tapping almost $1 billion in federal funding, agreed to deliver 100 million doses of its vaccine candidate for up to $1.5 billion.